| RECONCILIATION OF GAAP NET INCOME FROM CONTINUING OPERATIONS AND GAAP DILUTED NET INCOME PER COMMON SHARE FROM CONTINUING OPERATIONS ATTRIBUTABLE TO MICROCHIP TECHNOLOGY STOCKHOLDERS TO NON-GAAP NET INCOME FROM CONTINUING OPERATIONS AND NON-GAAP DILUTED NET INCOME PER COMMON SHARE FROM CONTINUING OPERATIONS ATTRIBUTABLE TO MICROCHIP TECHNOLOGY STOCKHOLDERS | |||||||||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||
| December 31, | December 31, | ||||||||||||||
| 2016 | 2015 | 2016 | 2015 | ||||||||||||
| Net income from continuing operations, as reported | $ | 107,335 | $ | 61,211 | $ | 33,684 | $ | 256,777 | |||||||
| Distributor revenue recognition adjustment, net of tax effect | 26,005 | 4,380 | 46,159 | 11,589 | |||||||||||
| Share-based compensation expense, net of tax effect | 14,744 | 11,505 | 69,467 | 36,537 | |||||||||||
| Manufacturing excursion, net of tax effect | — | — | 505 | — | |||||||||||
| Acquisition-related restructuring, acquired inventory valuation costs, intangible asset amortization and other costs, net of tax effect | 93,278 | 55,294 | 426,467 | 126,631 | |||||||||||
| Special charges (income) and other, net of tax effect | 12,387 | (4,817 | ) | 34,453 | 1,773 | ||||||||||
| Noncontrolling interests | — | — | — | (375 | ) | ||||||||||
| Gain on equity securities and equity method investment, net of tax effect | — | (52 | ) | (296 | ) | (16,116 | ) | ||||||||
| Impairment on available-for-sale investment, net of tax effect | 907 | 2,523 | 907 | 2,523 | |||||||||||
| Non-cash other expense, net of tax effect | 8,257 | 8,091 | 24,227 | 23,351 | |||||||||||
| Non-recurring tax events | (7,524 | ) | 301 | (10,335 | ) | (12,406 | ) | ||||||||
| Tax adjustment in accordance with ASC 740-270 | (8,841 | ) | — | 34,901 | — | ||||||||||
| Non-GAAP net income from continuing operations | $ | 246,548 | $ | 138,436 | $ | 660,139 | $ | 430,284 | |||||||
| Non-GAAP net income from continuing operations as a percentage of net sales | 28.0 | % | 25.1 | % | 25.4 | % | 26.2 | % | |||||||
| Diluted net income per common share from continuing operations attributable to Microchip Technology stockholders, as reported | $ | 0.46 | $ | 0.28 | $ | 0.14 | $ | 1.18 | |||||||
| Non-GAAP diluted net income per common share from continuing operations attributable to Microchip Technology stockholders | $ | 1.05 | $ | 0.64 | $ | 2.83 | $ | 1.98 | |||||||
| Diluted common shares outstanding, as reported | 235,424 | 217,975 | 233,351 | 217,280 | |||||||||||
| Diluted common shares outstanding Non-GAAP | 235,424 | 217,975 | 233,351 | 217,109 | |||||||||||
Microchip Technology Announces Outstanding Financial Results for Third Quarter Fiscal Year 2017
 |  | More IC News
|
|
RELATED NEWS
